rss
Br J Ophthalmol 1989;73:1015-1018 doi:10.1136/bjo.73.12.1015
  • Research Article

Ocular myasthenia gravis after D-penicillamine administration.

  1. L J Katz,
  2. R L Lesser,
  3. J R Merikangas and
  4. J P Silverman
  1. William and Anna Goldberg Glaucoma Service, Thomas Jefferson University, Philadelphia, PA 19107.

      Abstract

      A 68-year-old black woman who was put on D-penicillamine therapy (250-500 mg per day, total dose 15 g) for rheumatoid arthritis developed ocular myasthenia gravis. Two weeks after she discontinued D-penicillamine her signs and symptoms cleared with no other treatment. Review of previous cases and possible immunological mechanisms are discussed.

      This Article

      1. Abstract
      2. PDF

      Responses

      1. Submit a response
      2. No responses published

      Register for free content

      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.